Drawing for FOCAL THERAPEUTICS

USPTO serial 99473563

FOCAL THERAPEUTICS

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
TORRES, MIGUEL A
Law office
TMO LAW OFFICE 128

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FOCAL THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Bochner

Andrew D. Bochner Bochner PLLC1040 Avenue of the Americas, 15th FloorNew York, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
009Ultrasonic imaging apparatus, not for medical purposes; Microscopes; Downloadable software for the treatment of pathologies affecting various organs by ultrasound emission; Ultrasound diagnostic apparatus, not for medical purposes; Downloadable software for the generation and control of ultrasound; Downloadable software for the fusion of diagnostic images and treatment planning; Computers; Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying dataACTIVE—
010Medical ultrasound apparatus; Ultrasound apparatus for medical use; Apparatus for blood analysis; Anesthesia machines; Dialyzers; X-ray apparatus for medical use; Electrocardiographs; Medical electrodes; Irrigators for medical use; Lasers for medical purposes; X-ray apparatus for medical purposes; Catheters; Urethral catheters; Urinals being vessels; Urological imaging systems; Uterine syringes; Lithotripters; Operating tables; Furniture especially made for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 1, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 1, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jul 1, 2026CNSLSUSPENSION LETTER WRITTEN—
Jun 26, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 26, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 26, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2026DOCKASSIGNED TO EXAMINER—
Oct 31, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 31, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 31, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance